Annual Working Capital
$643.00 K
+$1.54 M+171.41%
December 31, 2024
Summary
- As of March 10, 2025, TELO annual working capital is $643.00 thousand, with the most recent change of +$1.54 million (+171.41%) on December 31, 2024.
- During the last 3 years, TELO annual working capital has risen by +$781.10 thousand (+565.60%).
- TELO annual working capital is now at all-time high.
Performance
TELO Working Capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Working Capital
$643.00 K
+$200.90 K+45.44%
December 31, 2024
Summary
- As of March 10, 2025, TELO quarterly working capital is $643.00 thousand, with the most recent change of +$200.90 thousand (+45.44%) on December 31, 2024.
- Over the past year, TELO quarterly working capital has stayed the same.
- TELO quarterly working capital is now -78.68% below its all-time high of $3.02 million, reached on March 31, 2024.
Performance
TELO Quarterly Working Capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Working Capital Formula
Working Capital = Current Assets − Current Liabilities
TELO Working Capital Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +171.4% | 0.0% |
| 3 y3 years | +565.6% | 0.0% |
| 5 y5 years | +565.6% | 0.0% |
TELO Working Capital Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +168.6% | -78.7% | +122.1% |
| 5 y | 5-year | at high | +168.6% | -78.7% | +122.1% |
| alltime | all time | at high | +168.6% | -78.7% | +122.1% |
Telomir Pharmaceuticals Working Capital History
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2024 | $643.00 K(-171.4%) | $643.00 K(+45.4%) |
| Sep 2024 | - | $442.10 K(-71.8%) |
| Jun 2024 | - | $1.57 M(-48.0%) |
| Mar 2024 | - | $3.02 M(-435.0%) |
| Dec 2023 | -$900.40 K | -$900.40 K(-69.0%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2023 | - | -$2.90 M(+50.0%) |
| Jun 2023 | - | -$1.94 M(+106.6%) |
| Dec 2022 | -$937.30 K(+578.7%) | - |
| Dec 2022 | - | -$937.30 K |
| Dec 2021 | -$138.10 K | - |
FAQ
- What is Telomir Pharmaceuticals annual working capital?
- What is the all time high annual working capital for Telomir Pharmaceuticals?
- What is Telomir Pharmaceuticals annual working capital year-on-year change?
- What is Telomir Pharmaceuticals quarterly working capital?
- What is the all time high quarterly working capital for Telomir Pharmaceuticals?
- What is Telomir Pharmaceuticals quarterly working capital year-on-year change?
What is Telomir Pharmaceuticals annual working capital?
The current annual working capital of TELO is $643.00 K
What is the all time high annual working capital for Telomir Pharmaceuticals?
Telomir Pharmaceuticals all-time high annual working capital is $643.00 K
What is Telomir Pharmaceuticals annual working capital year-on-year change?
Over the past year, TELO annual working capital has changed by +$1.54 M (+171.41%)
What is Telomir Pharmaceuticals quarterly working capital?
The current quarterly working capital of TELO is $643.00 K
What is the all time high quarterly working capital for Telomir Pharmaceuticals?
Telomir Pharmaceuticals all-time high quarterly working capital is $3.02 M
What is Telomir Pharmaceuticals quarterly working capital year-on-year change?
Over the past year, TELO quarterly working capital has changed by $0.00 (0.00%)